Matthew Ware
Baylor College of Medicine
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Matthew Ware.
Physical Review B | 2013
Joel Strand; Matthew Ware; Felix Beaudoin; Thomas Ohki; Blake Johnson; Alexandre Blais; B.L.T. Plourde
We demonstrate rapid, first-order sideband transitions between a superconducting resonator and a frequency-modulated transmon qubit. The qubit contains a substantial asymmetry between its Josephson junctions leading to a linear portion of the energy band near the resonator frequency. The sideband transitions are driven with a magnetic flux signal of a few hundred MHz coupled to the qubit. This modulates the qubit splitting at a frequency near the detuning between the dressed qubit and resonator frequencies, leading to rates up to 85 MHz for exchanging quanta between the qubit and resonator.
Physical Review A | 2013
Antonio Corcoles; Jay M. Gambetta; Jerry M. Chow; John A. Smolin; Matthew Ware; Joel Strand; B.L.T. Plourde; Matthias Steffen
We implement a complete randomized benchmarking protocol on a system of two superconducting qubits. The protocol consists of randomizing over gates in the Clifford group, which experimentally are generated via an improved two-qubit cross-resonance gate implementation and single-qubit unitaries. From this we extract an optimal average error per Clifford operation of
Scientific Reports | 2015
Matthew Ware; Sophia Tinger; Kevin L. Colbert; Stuart J. Corr; Paul Rees; Nadezhda V. Koshkina; Steven A. Curley; Huw D. Summers; Biana Godin
0.0936
ACS Nano | 2014
Matthew Ware; Biana Godin; Neenu Singh; Ravish Majithia; Sabeel Shamsudeen; Rita E. Serda; Kenith E. Meissner; Paul Rees; Huw D. Summers
. We also perform an interleaved experiment, alternating our optimal two-qubit gate with random two-qubit Clifford gates, to obtain a two-qubit gate error of
PLOS ONE | 2015
Stuart J. Corr; Sabeel Shamsudeen; Leoncio Vergara; Jason Chak-Shing Ho; Matthew Ware; Vazrik Keshishian; Kenji Yokoi; David J. Savage; Ismail M. Meraz; Warna D. Kaluarachchi; Brandon T. Cisneros; Mustafa Raoof; Duy Trac Nguyen; Yingchun Zhang; Lon J. Wilson; Huw D. Summers; Paul Rees; Steven A. Curley; Rita E. Serda
0.0653
Frontiers in Immunology | 2017
Fransisca Leonard; Louis T. Curtis; Matthew Ware; Taraz Nosrat; Xuewu Liu; Kenji Yokoi; Hermann B. Frieboes; Biana Godin
. We compare these values with a two-qubit gate error of
Cancer Nanotechnology | 2016
Norman A. Lapin; Martyna Krzykawska-Serda; Matthew Ware; Steven A. Curley; Stuart J. Corr
\ensuremath{\sim}0.12
Scientific Reports | 2017
Matthew Ware; Martyna Krzykawska-Serda; Jason Chak-Shing Ho; Jared M. Newton; Sarah Suki; Justin J. Law; Lam Nguyen; Vazrik Keshishian; Maciej Serda; Kimberly Taylor; Steven A. Curley; Stuart J. Corr
obtained from quantum process tomography, which is likely limited by state preparation and measurement errors.
Journal of Materials Chemistry B | 2014
Katherine Margulis; Srimeenakshi Srinivasan; Matthew Ware; Huw D. Summers; Biana Godin; Shlomo Magdassi
The importance of evaluating physical cues in cancer research is gradually being realized. Assessment of cancer cell physical appearance, or phenotype, may provide information on changes in cellular behavior, including migratory or communicative changes. These characteristics are intrinsically different between malignant and non-malignant cells and change in response to therapy or in the progression of the disease. Here, we report that pancreatic cancer cell phenotype was altered in response to a physical method for cancer therapy, a non-invasive radiofrequency (RF) treatment, which is currently being developed for human trials. We provide a battery of tests to explore these phenotype characteristics. Our data show that cell topography, morphology, motility, adhesion and division change as a result of the treatment. These may have consequences for tissue architecture, for diffusion of anti-cancer therapeutics and cancer cell susceptibility within the tumor. Clear phenotypical differences were observed between cancerous and normal cells in both their untreated states and in their response to RF therapy. We also report, for the first time, a transfer of microsized particles through tunneling nanotubes, which were produced by cancer cells in response to RF therapy. Additionally, we provide evidence that various sub-populations of cancer cells heterogeneously respond to RF treatment.
2013 IEEE 14th International Superconductive Electronics Conference (ISEC) | 2013
Daniela F. Bogorin; Matthew Ware; Doug McClure; Stephen Sorokanich; B.L.T. Plourde
Understanding the effect of variability in the interaction of individual cells with nanoparticles on the overall response of the cell population to a nanoagent is a fundamental challenge in bionanotechnology. Here, we show that the technique of time-resolved, high-throughput microscopy can be used in this endeavor. Mass measurement with single-cell resolution provides statistically robust assessments of cell heterogeneity, while the addition of a temporal element allows assessment of separate processes leading to deconvolution of the effects of particle supply and biological response. We provide a specific demonstration of the approach, in vitro, through time-resolved measurement of fibroblast cell (HFF-1) death caused by exposure to cationic nanoparticles. The results show that heterogeneity in cell area is the major source of variability with area-dependent nanoparticle capture rates determining the time of cell death and hence the form of the exposure–response characteristic. Moreover, due to the particulate nature of the nanoparticle suspension, there is a reduction in the particle concentration over the course of the experiment, eventually causing saturation in the level of measured biological outcome. A generalized mathematical description of the system is proposed, based on a simple model of particle depletion from a finite supply reservoir. This captures the essential aspects of the nanoparticle–cell interaction dynamics and accurately predicts the population exposure–response curves from individual cell heterogeneity distributions.